Personalized dosing via pharmacokinetic monitoring of 5-fluorouracil might reduce toxicity in early- or late-stage colorectal cancer patients treated with infusional 5-fluorouracil-based chemotherapy regimens.
暂无分享,去创建一个
E. Messaris | W. El-Deiry | L. Poritz | K. McKenna | C. L. Kline | Junjia Zhu | K. Staveley-O’Carroll | H. Harvey | H. Mackley | Cheryl Beachler | J. Sivik | H. Sheikh | Angelique Schiccitano | D. Stewart